Cargando…
Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer
Testicular germ cell tumor (TGCT), the most common cancer in men aged 18 to 45 years, has a strong heritable basis. Genome-wide association studies (GWAS) have proposed single nucleotide polymorphisms (SNPs) at a number of loci influencing TGCT risk. To further evaluate the association of recently p...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849160/ https://www.ncbi.nlm.nih.gov/pubmed/29560096 http://dx.doi.org/10.18632/oncotarget.23117 |
_version_ | 1783306006079471616 |
---|---|
author | Loveday, Chey Litchfield, Kevin Levy, Max Holroyd, Amy Broderick, Peter Kote-Jarai, Zsofia Dunning, Alison M Muir, Kenneth Peto, Julian Eeles, Rosalind Easton, Douglas F Dudakia, Darshna Orr, Nick Pashayan, Nora Reid, Alison Huddart, Robert A Houlston, Richard S Turnbull, Clare |
author_facet | Loveday, Chey Litchfield, Kevin Levy, Max Holroyd, Amy Broderick, Peter Kote-Jarai, Zsofia Dunning, Alison M Muir, Kenneth Peto, Julian Eeles, Rosalind Easton, Douglas F Dudakia, Darshna Orr, Nick Pashayan, Nora Reid, Alison Huddart, Robert A Houlston, Richard S Turnbull, Clare |
author_sort | Loveday, Chey |
collection | PubMed |
description | Testicular germ cell tumor (TGCT), the most common cancer in men aged 18 to 45 years, has a strong heritable basis. Genome-wide association studies (GWAS) have proposed single nucleotide polymorphisms (SNPs) at a number of loci influencing TGCT risk. To further evaluate the association of recently proposed risk SNPs with TGCT at 2q14.2, 3q26.2, 7q36.3, 10q26.13 and 15q21.3, we analyzed genotype data on 3,206 cases and 7,422 controls. Our analysis provides independent replication of the associations for risk SNPs at 2q14.2 (rs2713206 at P = 3.03 × 10(−2); P-meta = 3.92 × 10–8; nearest gene, TFCP2L1) and rs12912292 at 15q21.3 (P = 7.96 × 10(−11); P-meta = 1.55 × 10(−19); nearest gene PRTG). Case-only analyses did not reveal specific associations with TGCT histology. TFCP2L1 joins the growing list of genes located within TGCT risk loci with biologically plausible roles in developmental transcriptional regulation, further highlighting the importance of this phenomenon in TGCT oncogenesis. |
format | Online Article Text |
id | pubmed-5849160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-58491602018-03-20 Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer Loveday, Chey Litchfield, Kevin Levy, Max Holroyd, Amy Broderick, Peter Kote-Jarai, Zsofia Dunning, Alison M Muir, Kenneth Peto, Julian Eeles, Rosalind Easton, Douglas F Dudakia, Darshna Orr, Nick Pashayan, Nora Reid, Alison Huddart, Robert A Houlston, Richard S Turnbull, Clare Oncotarget Research Paper Testicular germ cell tumor (TGCT), the most common cancer in men aged 18 to 45 years, has a strong heritable basis. Genome-wide association studies (GWAS) have proposed single nucleotide polymorphisms (SNPs) at a number of loci influencing TGCT risk. To further evaluate the association of recently proposed risk SNPs with TGCT at 2q14.2, 3q26.2, 7q36.3, 10q26.13 and 15q21.3, we analyzed genotype data on 3,206 cases and 7,422 controls. Our analysis provides independent replication of the associations for risk SNPs at 2q14.2 (rs2713206 at P = 3.03 × 10(−2); P-meta = 3.92 × 10–8; nearest gene, TFCP2L1) and rs12912292 at 15q21.3 (P = 7.96 × 10(−11); P-meta = 1.55 × 10(−19); nearest gene PRTG). Case-only analyses did not reveal specific associations with TGCT histology. TFCP2L1 joins the growing list of genes located within TGCT risk loci with biologically plausible roles in developmental transcriptional regulation, further highlighting the importance of this phenomenon in TGCT oncogenesis. Impact Journals LLC 2017-12-07 /pmc/articles/PMC5849160/ /pubmed/29560096 http://dx.doi.org/10.18632/oncotarget.23117 Text en Copyright: © 2018 Loveday et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Paper Loveday, Chey Litchfield, Kevin Levy, Max Holroyd, Amy Broderick, Peter Kote-Jarai, Zsofia Dunning, Alison M Muir, Kenneth Peto, Julian Eeles, Rosalind Easton, Douglas F Dudakia, Darshna Orr, Nick Pashayan, Nora Reid, Alison Huddart, Robert A Houlston, Richard S Turnbull, Clare Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer |
title | Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer |
title_full | Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer |
title_fullStr | Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer |
title_full_unstemmed | Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer |
title_short | Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer |
title_sort | validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849160/ https://www.ncbi.nlm.nih.gov/pubmed/29560096 http://dx.doi.org/10.18632/oncotarget.23117 |
work_keys_str_mv | AT lovedaychey validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT litchfieldkevin validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT levymax validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT holroydamy validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT broderickpeter validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT kotejaraizsofia validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT dunningalisonm validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT muirkenneth validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT petojulian validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT eelesrosalind validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT eastondouglasf validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT dudakiadarshna validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT orrnick validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT pashayannora validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT reidalison validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT huddartroberta validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT houlstonrichards validationoflociat2q142and15q213asriskfactorsfortesticularcancer AT turnbullclare validationoflociat2q142and15q213asriskfactorsfortesticularcancer |